UBC experts are available to discuss the impacts of fentanyl from pharmacological, medical and public health perspectives.
M-J Milloy, epidemiologist
Department of Medicine at UBC, Centre for Excellence in HIV/AIDS
– contribution of fentanyl to overdose patterns in BC
– measures to respond to drug overdoses
Dr. Thomas Kerr
Department of Medicine at UBC, Urban Health Research Initiative at the B.C. Centre for Excellence in HIV/AIDS
– overdose risks and interventions
Email: drtk@cfenet.ubc.ca
Please direct media requests for Milloy and Kerr to:
Caroline Dobuzinskis
Communications Coordinator
BC Centre for Excellence in HIV/AIDS
Tel: 604-682-2344 ext. 66536
Cell: 604-366-6540
E-mail: cdobuzin@cfenet.ubc.ca
Mahyar Etminan
Pharmacologist
Department of Ophthalmology and Visual Sciences
– clinical pharmacology
– potency
– medical use and applications
E-mail: metminan@popi.ubc.ca
Tel: 604–875–2000
Cell: 778–846–9604
Dr. Brian Warriner
Department of Anesthesiology, Pharmacology and Therapeutics
– use of fentanyl in hospitals
– effectiveness as part of an anesthetic
– use in pain management
– side effects, both minor and severe.
Tel: 604-961-7021
E-mail: brian.warriner@ubc.ca
Jane Buxton
School of Population and Public Health
Harm reduction lead at BC Centre for Disease Control
E-mail: jane.buxton@ubc.ca